Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $157.95M.
ENTERPRISE VALUE (EV)
$157.95M
Zentalis Pharmaceuticals, Inc.
Market Cap
$190.07M
Enterprise Value (EV)
$157.95M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | $190.07M | $157.95M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | $182.77M |
| RxSight, Inc. (RXST)vs › | $192.49M | $189.72M |
| Surrozen, Inc. (SRZN)vs › | $197.18M | $101.46M |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | $138.28M |
| Exagen Inc. (XGN)vs › | $197.87M | $198.83M |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | $114.57M |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | $143.23M |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | $153.93M |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | $164.74M |
Market Cap
$190.07M
Total Debt
$3.87M
Cash
$35.99M
Enterprise Value
$157.95M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
